Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Retinoblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Triple Negative Breast Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Mantle-Cell 1Leukemia, Monocytic, Acute 1Leukemia 1Hodgkin Disease 1Hepatoblastoma 1Febrile Neutropenia 1Fallopian Tube Neoplasms 1Chemotherapy-induced Neutropenia 1Chemotherapy-Induced Febrile Neutropenia 1Breast Neoplasms 1

Interventions

sodium thiosulfate 1Therapeutics 1Sorafenib 1Psychiatric Rehabilitation 1Ocoxin 1Melphalan 1Mannitol 1Ifosfamide 1ICE protocol 5 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Bevacizumab 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasms, Germ Cell and Embryonal × Granulocyte Colony-Stimulating Factor × Clear all
NCT00127049 2006-09-08

Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown
37 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡